The placental transfer of alcuronium was studied in twelve patients undergoing elective or emergency caesarean section. Umbilical cord vein and maternal plasma was analysed for alcuronium at dose-delivery time intervals ranging from 5 to 10.5 minutes. The mean umbilical vein concentration of the relaxant was 0.41 ± 0.18 (SD) μg/ml, and the mean foetal/maternal concentration ratio was 0.26 ± 0.11. A positive correlation between foetal and maternal concentrations of alcuronium was demonstrated. Although alcuronium appears to cross the placenta rapidly and in reasonably high concentration, no apparent adverse effects on the neonates was evident as judged by measurement of Apgar scores.
ThomasJ., ClimieC.R., MatherL.E.Placental transfer of alcuronium. Br J Anaesth1969; 41: 297–301.
2.
KerstenU.W., MeijerD.K.F., AgostonS.Fluorimetric and chromatographic determination of pancuronium bromide and its metabolites in biological materials. Clinica Chimica Acta1973; 44: 59–66.
3.
CalveyT.N., WilsonW.Muscle relaxant drugs and their antagonists. In: GrayT.C., NunnJ.F., UttingJ.E. eds. General Anaesthesia.London: Butterworths1980; 319–335.
4.
WalkerJ.S., TriggsE.J., ShanksC.A.Clinical pharmacokinetics of alcuronium chloride in man. Eur J Clin Pharmacol1980; 17: 449–457.
5.
MoyaF., SmithB.E.Uptake, distribution and placental transport of drugs and anesthetics. Anaesthesiology1965; 26: 465–476.
6.
SpeirsI., SimA.W.The placental transfer of pancuronium bromide. Br J Anaesth1972; 44: 370–373.
7.
BoothP.N., WatsonM.J., MacleodK.Pancuronium and the placental barrier. Anaesthesia1977; 32: 320–323.
8.
DuvaldestinP., DemetriouM., HenzelD., DesmontsJ.M.The placental transfer of pancuronium and its pharmacokinetics during caesarean section. Acta Anaesth Scand1978; 22: 327–333.
9.
AbouleishE., WingardL.B., De La VegaS., UyN.Pancuronium in caesarean section and its placental transfer. Br J Anaesth1980; 52: 531–536.
10.
DrabkovaJ., CrulJ.F., Van Der KleijnE.Placental transfer of 14C-succinylcholine in near-term macaca mulatta monkeys. Br J Anaesth1973; 45: 1087–1095.
11.
KivaloI., SaarikoskiS.Placental transfer of 14C-dimethyltubocurarine during caesarean section. Br J Anaesth1976; 48: 239–242.
12.
OhY., MirkinB.L.Transfer of drugs into the central nervous system and across the placenta: A comparative study utilizing aminopyrine (A), diphenylhydantoin (D), sodium salicylate (S) and mecamylamine (M). Federation Proceedings1971; 30: 2034.
13.
GarrettsonL.K., ProcknalJ.A., LevyG.Fetal acquisition and neonatal elimination of a large amount of salicylate. Clin Pharmacol Ther1975; 17: 98–103.
14.
LevyG., ProcknalJ.A., GarrettsonL.K.Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium. Clin Pharmacol Ther1975; 18: 210–214.
15.
CochranT.E.The distribution of immunoglobulin and albumin between maternal and cord serum at delivery. J Obstet Gynaecol1974; 81: 980–987.
16.
HyttenF.E., LindT.Diagnostic indices in pregancy.Documenta Geigy, Basle1973; 47.
17.
RaaflaubJ., FreyP.Zur pharmacokinetik von diallylnor-toxiferin beim menschen. Arzeimittel-Forschung1972; 22: 73–78.
18.
StovnerJ., TheodorsenL., BjelkeE.Sensitivity to tubocurarine and alcuronium with special reference to plasma protein pattern. Br J Anaesth1971; 43: 385–391.
